Vitamin D—A New Therapeutic Target in the Management of Type 2 Diabetes Patients
Oana Albai,Adina Braha,Bogdan Timar,Ioana Golu,Romulus Timar
DOI: https://doi.org/10.3390/jcm13051390
IF: 3.9
2024-02-29
Journal of Clinical Medicine
Abstract:Background: Vitamin D is a fat-soluble vitamin that prevents cardiovascular diseases and diabetes mellitus (DM). The present research aimed to study the impact of 25-hydroxyvitamin D (25(OH)D) level on the health status of patients with type 2 DM (T2DM) hospitalized in the "Pius Brînzeu" Emergency Clinical County University Hospital in Timisoara, Romania. Methods: The study retrospectively included 160 patients with T2DM who were clinically and biologically evaluated during hospitalization. Results: 13.1% of patients had optimal, 23.1% insufficient, and 63.8% deficient 25(OH)D values. Patients with 25(OH)D deficiency presented poorer glycemic control and were older, with higher weight, but had altered renal function, anemia, and lower iron values. Also, patients with associated neoplasia, diabetic neuropathy, cardiovascular disease (CVD), dementia, and grade 3 arterial hypertension (HTN) had lower values of 25(OH)D. An age > 55 years (sensitivity 69.9, specificity 82.5, AUROC 0.786, p 7.7% (sensitivity 89.3, specificity 92.9, AUROC 0.938, p < 0.001) predict 25(OH)D deficiency in T2DM patients. Conclusions: Vitamin D influences almost every system and organ in the body, so it should be a routine test for all patients with DM to correct the deficiency and prevent other diseases and complications.
medicine, general & internal
What problem does this paper attempt to address?
The problem this paper attempts to address is the impact of 25-hydroxyvitamin D (25(OH)D) levels on the health status of patients with type 2 diabetes mellitus (T2DM). Specifically, the study aims to assess the vitamin D levels of hospitalized T2DM patients and analyze the relationship between these levels and the patients' health status. The study found that vitamin D deficiency is associated with poor glycemic control, older age, higher body weight, and impaired renal function. Additionally, T2DM patients with tumors, diabetic neuropathy, cardiovascular disease (CVD), dementia, and grade 3 hypertension also exhibited lower 25(OH)D levels. The findings suggest that vitamin D affects almost all systems and organs, and therefore, it is recommended to include vitamin D testing as a routine examination for all diabetes patients to correct deficiencies and prevent other diseases and complications.